Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Conference, Webcast

Fourth Bioelectronic Medicine Summit Showcases Broad Innovation


Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research ? the global scientific home of bioelectronic medicine ? on September 23 and 24.

Bioelectronic medicine combines molecular medicine, neuroscience, and biomedical engineering to develop innovative therapies to treat a variety of diseases and conditions through targeted stimulation of nerves, including paralysis, arthritis, pulmonary hypertension, and inflammatory bowel disease. Due to coronavirus disease 2019 (COVID-19), this year's summit was held virtually and drew nearly 200 attendees, including esteemed academic leaders, members of the media, and industry professionals.

"Even though our recent focus has been on discovering a COVID-19 treatment, we continue to research, invest and lead in bioelectronic medicine," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. "It was an honor to bring together some of the most influential experts to explore, define, and propel this exciting field of science even further."

Key highlights from the symposium include:

"It is exciting to hear, and see first-hand from the people leading progress in bioelectronic medicine," said Valentin Pavlov, PhD, professor in the Feinstein Institutes' Institute of Bioelectronic Medicine and co-chair of the summit. "It is important that collectively, researchers from around the globe continue to share their knowledge and help evolve this flourishing and promising field of science."

Breakthroughs in engineering such as miniature electrodes, flexible sensors, methods of controlling and observing vagus nerve stimulation were among the presentation topics. In addition to video presentations, exhibitions, Q&A sessions, and networking opportunities, more than 23 research poster abstracts were displayed ? giving attendees a glimpse into what's on the horizon for bioelectronic medicine.

"We are at the forefront of a medical and technological revolution," said Sangeeta Chavan, PhD, professor in the Feinstein Institutes' Institute of Bioelectronic Medicine and co-chair of the summit. "These lectures, presentations and open-dialogue conversations strengthen our view that bioelectronic medicine will treat the world's most complex disorders, potentially even better than pharmacologics."

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine ? a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.


These press releases may also interest you

at 04:17
BioArctic AB (publ) announced today that the company's partner Eisai will conduct four oral presentations related to the drug candidate BAN2401 (lecanemab) at the 13th Clinical Trials on Alzheimer's Disease Conference (CTAD) on November 4-7....

at 04:05
Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. ("BevCanna" or the "Company") is pleased to announce the addition of retail beverage marketer Donald Wood to the Company's Independent Advisory Board....

at 04:00
Rarecells, Inc. (USA), a leading Liquid Biopsy company, is pleased to announce that National Institute of Integrative Medicine's (Melbourne, Australia) researchers obtained striking results in a group of Australian men using the ISET® test for early...

at 04:00
On October 28, 2020, Yuyu Pharm (CEO Robert Wonsang Yu, KRX 000220) initiated steps to incorporate ISO 37001 Anti-bribery management system to strengthen the company's compliance system. During the introduction ceremony of ISO 37001 held at Yuyu...

at 04:00
The U.S. Bureau of Labor Statistics reports that home health care careers are expected to grow by 34% through 2029, which is much faster than average. As people increasingly have a need for home health care, the need for highly trained home health...

at 03:50
UNION therapeutics A/S ("UNION"), a privately held clinical stage pharmaceutical company focusing on infectious and inflammatory diseases, announced further strengthening of the leadership team. During 2020, UNION has significantly expanded the...



News published on 28 september 2020 at 10:35 and distributed by: